BROOKS MAYS
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism SOUTHERN PINES, NC NPI 1124134010
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism NC Lilly USA, LLC All categories
General Payments — all program years on this page
$67,571.51
- Category: General Payments
- Program years: PY2018–2024
- Record count: 855
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,872.25 across 102 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,872.25 | 102 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $428.32 | 23 |
| Novo Nordisk AS | $262.02 | 19 |
| Abbott Laboratories | $142.38 | 7 |
| SANOFI-AVENTIS U.S. LLC | $118.40 | 5 |
| Insulet Corporation | $89.81 | 4 |
| RECORDATI_RARE_DISEASES_INC. | $82.34 | 4 |
| Bayer HealthCare Pharmaceuticals Inc. | $79.82 | 5 |
| Corcept Therapeutics | $75.65 | 4 |
| Kyowa Kirin, Inc. | $69.66 | 3 |
| Amgen Inc. | $67.07 | 4 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $62.64 | 3 |
| BETA BIONICS, INC. | $46.52 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $42.44 | 3 |
| ABBVIE INC. | $36.35 | 2 |
| Radius Health, Inc. | $36.08 | 2 |
| CeQur Corporation | $32.48 | 1 |
| Neurocrine BioSciences, Inc. | $22.96 | 1 |
| Rhythm Pharmaceuticals, Inc. | $22.61 | 1 |
| IBSA Pharma Inc. | $22.46 | 1 |
| Acerta Pharma LLC | $20.74 | 1 |
| Medtronic, Inc. | $16.76 | 1 |
| Amneal Pharmaceuticals LLC | $16.62 | 1 |
| Ascendis Pharma Inc | $16.57 | 1 |
| Azurity Pharmaceuticals, Inc. | $16.17 | 1 |
| Tandem Diabetes Care, Inc. | $15.51 | 1 |
| MannKind Corporation | $15.14 | 1 |
| Inspire Medical Systems, Inc. | $14.73 | 1 |
By program year
Records — PY2024 (102)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.